Pacer Advisors Inc. grew its holdings in shares of Cognex Co. (NASDAQ:CGNX – Free Report) by 1.7% during the 4th quarter, Holdings Channel reports. The institutional investor owned 25,685 shares of the scientific and technical instruments company’s stock after acquiring an additional 422 shares during the quarter. Pacer Advisors Inc.’s holdings in Cognex were worth $921,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. raised its holdings in shares of Cognex by 9.4% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,055 shares of the scientific and technical instruments company’s stock worth $164,000 after purchasing an additional 349 shares during the last quarter. Advisors Asset Management Inc. grew its position in Cognex by 123.1% during the 3rd quarter. Advisors Asset Management Inc. now owns 714 shares of the scientific and technical instruments company’s stock worth $29,000 after purchasing an additional 394 shares during the period. First Horizon Advisors Inc. raised its stake in shares of Cognex by 20.1% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,732 shares of the scientific and technical instruments company’s stock valued at $111,000 after buying an additional 457 shares during the last quarter. Fiduciary Trust Co lifted its holdings in shares of Cognex by 9.6% in the 3rd quarter. Fiduciary Trust Co now owns 5,443 shares of the scientific and technical instruments company’s stock valued at $220,000 after buying an additional 475 shares during the period. Finally, MML Investors Services LLC boosted its stake in shares of Cognex by 4.0% in the third quarter. MML Investors Services LLC now owns 12,491 shares of the scientific and technical instruments company’s stock worth $506,000 after buying an additional 478 shares during the last quarter. Institutional investors own 88.12% of the company’s stock.
Cognex Price Performance
NASDAQ CGNX opened at $38.95 on Tuesday. Cognex Co. has a 1-year low of $34.79 and a 1-year high of $53.13. The company has a market cap of $6.68 billion, a PE ratio of 74.91 and a beta of 1.40. The stock’s 50 day simple moving average is $38.14 and its 200-day simple moving average is $39.76.
Insider Buying and Selling at Cognex
Analyst Upgrades and Downgrades
CGNX has been the subject of several recent research reports. Stephens reiterated an “overweight” rating and set a $55.00 price target on shares of Cognex in a research report on Thursday, January 2nd. Citigroup cut their target price on shares of Cognex from $44.00 to $42.00 and set a “neutral” rating for the company in a report on Monday, January 13th. Cantor Fitzgerald raised shares of Cognex to a “strong-buy” rating in a report on Friday, December 20th. Truist Financial lifted their price objective on shares of Cognex from $42.00 to $43.00 and gave the company a “hold” rating in a report on Thursday, January 16th. Finally, Needham & Company LLC lowered their target price on shares of Cognex from $50.00 to $47.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. One analyst has rated the stock with a sell rating, five have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $47.92.
Check Out Our Latest Research Report on CGNX
Cognex Company Profile
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Stories
- Five stocks we like better than Cognex
- Insider Trades May Not Tell You What You Think
- How to Invest in Small Cap Stocks
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- These Are the Dividend Stocks Insiders Bought in January
- How to Invest in Biotech Stocks
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.